Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia
Crossref DOI link: https://doi.org/10.1007/s40258-016-0285-7
Published Online: 2016-10-11
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cesarec, August
Likić, Robert http://orcid.org/0000-0003-1413-4862
License valid from 2016-10-11